Chagas disease: from discovery to a worldwide health problem

KCF Lidani, FA Andrade, L Bavia… - Frontiers in public …, 2019 - frontiersin.org
Carlos Chagas discovered American trypanosomiasis, also named Chagas disease (CD) in
his honor, just over a century ago. He described the clinical aspects of the disease …

[HTML][HTML] Chagas disease research and development: Is there light at the end of the tunnel?

E Chatelain - Computational and structural biotechnology journal, 2017 - Elsevier
Chagas disease, or American trypanosomiasis, is the result of infection by the parasite
Trypanosoma cruzi. It is endemic in Latin America, and spreading around the globe due to …

The global burden of disease study 2013: What does it mean for the NTDs?

JR Herricks, PJ Hotez, V Wanga… - PLoS neglected …, 2017 - journals.plos.org
The Global Burden of Disease Study (GBD) is a landmark initiative that systematically
quantifies the prevalence, morbidity, and mortality for hundreds of diseases, injuries, and …

Electrocardiographic abnormalities in Chagas disease in the general population: A systematic review and meta-analysis

LZ Rojas, M Glisic, L Pletsch-Borba… - PLoS neglected …, 2018 - journals.plos.org
Background Chagas disease (CD) is a major public health concern in Latin America and a
potentially serious emerging threat in non-endemic countries. Although the association …

Phenotypic screening approaches for Chagas disease drug discovery

E Chatelain, JR Ioset - Expert opinion on drug discovery, 2018 - Taylor & Francis
Introduction: Chagas disease, caused by the parasite Trypanosoma cruzi, is a global public
health issue. Current treatments targeting the parasite are limited to two old nitroheterocyclic …

A systematic review of historical and current trends in Chagas disease

DA Álvarez-Hernández… - Therapeutic …, 2021 - journals.sagepub.com
Introduction: Chagas disease (CD) is caused by Trypanosoma cruzi. When acquired, the
disease develops in stages. For diagnosis, laboratory confirmation is required, and an …

Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta‐analysis

S Chadalawada, A Rassi Jr, O Samara… - ESC Heart …, 2021 - Wiley Online Library
Aims This study aimed to estimate the annual mortality risk and its determinants in chronic
Chagas cardiomyopathy. Methods and results We conducted a systematic search in …

Animal models of Chagas disease and their translational value to drug development

E Chatelain, I Scandale - Expert Opinion on Drug Discovery, 2020 - Taylor & Francis
Introduction American trypanosomiasis, better known as Chagas disease, is a global public
health issue. Current treatments targeting the causative parasite, Trypanosoma cruzi, are …

The case for the development of a Chagas disease vaccine: why? How? When?

E Dumonteil, C Herrera - Tropical Medicine and Infectious Disease, 2021 - mdpi.com
Chagas disease is a major neglected tropical disease, transmitted predominantly by
triatomine insect vectors, but also through congenital and oral routes. While endemic in the …

[HTML][HTML] How universal is coverage and access to diagnosis and treatment for Chagas disease in Colombia? A health systems analysis

ZM Cucunubá, JM Manne-Goehler, D Díaz… - Social Science & …, 2017 - Elsevier
Limited access to Chagas disease diagnosis and treatment is a major obstacle to reaching
the 2020 World Health Organization milestones of delivering care to all infected and ill …